ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,290Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 2604

$571K Total Retail Price of All Prescriptions

Rank: 139 out of 2604

336 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,955 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 618 375 S3 1 1
LEVOTHYROXINE SODIUM 449 428 2 4
OMEPRAZOLE 447 391 3 5
LISINOPRIL 425 395 4 3
FUROSEMIDE 384 353 5 8
SIMVASTATIN 363 342 6 2
ATENOLOL 315 272 7 11
METOPROLOL TARTRATE 260 253 8 9
POTASSIUM CHLORIDE 209 191 9 16
NAMENDA 202 202 10 37
AMLODIPINE BESYLATE 174 155 11 6
DONEPEZIL HCL 152 152 12 28
WARFARIN SODIUM 151 137 13 13
ISOSORBIDE MONONITRATE ER 147 139 14 38
TRAMADOL HCL 143 131 15 15
MELOXICAM 133 130 16 36
LANTUS 130 120 17 40
GABAPENTIN 121 102 18 12
TAMSULOSIN HCL 105 105 19 30
ZOLPIDEM TARTRATE 102 63 20 21
LOSARTAN POTASSIUM 97 88 21 20
FENTANYL 94 82 S2 22 48
HYDROCHLOROTHIAZIDE 89 88 23 10
CYMBALTA 89 75 23 44
METOPROLOL SUCCINATE 88 88 25 17
DIVALPROEX SODIUM 86 86 26 81
NYSTATIN 85 83 27 100
GLYBURIDE 82 72 R 28 83
RANITIDINE HCL 78 70 29 25
ALLOPURINOL 72 70 30 35
PAROXETINE HCL 70 66 31 62
ATORVASTATIN CALCIUM 69 64 32 19
MIRTAZAPINE 68 68 33 52
NOVOLIN N 68 56 33 336
CLOPIDOGREL 64 58 35 39
CIPROFLOXACIN HCL 64 61 35 59
PRAVASTATIN SODIUM 63 63 37 14
CARVEDILOL 61 51 38 26
ADVAIR DISKUS 60 38 39 41
METFORMIN HCL ER 56 40 40 72
OXYBUTYNIN CHLORIDE ER 55 55 41 110
SPIRIVA 55 55 41 45
METFORMIN HCL 54 38 43 7
TRAZODONE HCL 53 38 44 46
GLIPIZIDE 52 51 45 51
CARISOPRODOL 50 0 R 46 54
SERTRALINE HCL 50 50 46 23
DIVALPROEX SODIUM ER 50 46 46 212
KLOR-CON M20 50 31 46 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.